A61L26/0033

USE OF PHOTOSYNTHETIC SCAFFOLDS IN TISSUE ENGINEERING

The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.

OIL-BASED WOUND CARE COMPOSITIONS AND METHODS
20200405637 · 2020-12-31 · ·

Compositions and methods for wound care or the dressing or treatment of wounds in a subject in need thereof. The compositions include an oil-based carrier, a polar solvent comprising one or more polar antimicrobial agents, and collagen or a collagen-based material. In at least some instances, the polar solvent comprising the one or more polar antimicrobial agents and the collagen or collagen-based material are suspended in the oil-based carrier.

WOUND HEALING COMPOSITIONS

Provided herein are biologically active solution compositions comprising one or more sacrificial proteolytic enzyme substrates, one or more preservatives, and one or more antimicrobial agents and methods of using the solution compositions to treat tissue sites, in particular chronic wounds. The compositions may be used in conjunction with negative pressure wound therapy to treat tissue sites.

Composition and products comprising senescent cells for use in tissue regeneration
10869900 · 2020-12-22 · ·

The present invention relates to in vitro cultured senescent cells, such as epithelial cells, keratinocytes and/or fibroblasts as well as their use in the treatment of tissue regeneration, particularly for the treatment of wounds such as burns or ulcers or the treatment of inflammatory conditions. Optionally, products may be used in combination with further drugs including antimicrobial or antidiabetic agents.

SYSTEMS AND METHODS FOR TREATING A WOUND WITH WOUND PACKING
20200390930 · 2020-12-17 ·

Methods for treating a wound with a wound packing are discussed. While the wound packing can include any suitable component, in some cases, it includes a collection of multi-potent cells (e.g., cells from bone marrow, amniotic membrane tissue, amniotic fluid, stem cells, etc.), plasma (e.g., concentrated and/or platelet rich plasma), and collagen (e.g., native and/or organized reconstituted collagen). In some cases, the wound packing is gelled, coagulated, or otherwise hardened through the use of thrombin, calcium chloride, and/or another suitable additive. In some cases, the wound packing is shaped to substantially correspond to the wound's shape. While the wound packing can be used in any suitable manner, in some instances, it is applied to the wound, skin fragments are applied to the packing, the packing is secured to the wound, and/or the packing is covered with a protective barrier. Other implementations are also described.

Methods and systems for stiffening of tissue for improved processing

Methods and systems for stiffening of tissue are presented to allow improved processing. Solutions including an acid or a base can be contacted with tissue to stiffen one or more components of the tissue. The resulting stiffened tissue can be used in the creation of wound treatment devices.

COLLAGEN-FIBRIN COMPOSITION, METHOD AND WOUND ARTICLES
20200353122 · 2020-11-12 ·

A method is described. The method includes mixing fibrin and collagen to form a mixture including collagen and fibrin; and reducing the salt concentration below the threshold concentration to form a fibrin. A collagen-fibrin composition is also described. The composition includes a collagen and a fibrin; wherein the composition has a salt concentration below the threshold concentration to form a fibrin.

MUTABLE COLLAGENOUS TISSUE FROM ECHINODERMS
20200354431 · 2020-11-12 ·

The present disclosure relates generally to methods for extracting or purifying collagen type I from marine animals, and uses of the purified collagen type I. Disclosed herein are the methods for the purification of highly pure mutable collagenous tissue from echinoderms. The current disclosure also relates to pharmaceutical, cosmetic and nutritional applications of the mutable collagenous tissue purified using the methods disclosed herein, and to compositions, kits and articles of manufacture made from the mutable collagenous tissue purified using the methods disclosed herein.

Wound healing compositions

Provided herein are biologically active solution compositions comprising one or more sacrificial proteolytic enzyme substrates, one or more preservatives, and one or more antimicrobial agents and methods of using the solution compositions to treat tissue sites, in particular chronic wounds. The compositions may be used in conjunction with negative pressure wound therapy to treat tissue sites.

SHAPE MEMORY ADHESIVE MATERIALS FOR DIABETIC WOUND HEALING

A shape memory adhesive material for adhering and contracting wounds, particularly diabetic wounds, to facilitate their closure and healing. The shape memory adhesive is pre-stretched and dried to provide an adhesive structure with a pre-programmed strain, wherein the adhesive is capable of rapid robust adhesion followed by predictive contraction upon contact with a wet surface. According to preferred embodiments, the shape memory adhesive material includes a combination of one or more hydrophilic polymers or copolymers, one or more amine coupling group, and one or more cross linkers.